About Metacrine

Metacrine is a privately held biotech company founded in 2015 on technology licensed from the laboratory of Dr. Ronald Evans, a world leader in nuclear hormone receptors and Howard Hughes Medical Institute Investigator at the Salk Institute. Metacrine will leverage two mechanistically distinct programs to target diabetes, steatohepatitis and other metabolic and liver disorders.

Latest News

08/15/2017
Metacrine Announces Collaboration on Development of FGF1 Variants for Glucose Lowering and Improving Insulin Sensitivity

04/11/2017
Metacrine to Present Two Abstracts on its Novel FXR Non-Bile Acid Agonist Program at the EASL International Liver Congress 2017

SEE ALL NEWS

Contact Us

Metacrine, Inc.
12780 El Camino Real, Suite #301
San Diego, CA 92130

P: (858) 369-7800
F: (858) 369-7801

Information
info@metacrine.com

Employment
careers@metacrine.com